Monte Rosa Therapeutics to Present at the UBS Targeted Protein Degradation Day
BOSTON, July 08, 2024 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular […]
Outlook Therapeutics® Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
UK MHRA marketing authorization follows recent European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) in the EU for the treatment […]
SRIVARU (SVMH) Deploys Advanced AI Platform to Manage Lead Generation Platform for PRANA 2.0 Electric Motorcycle
GRAND CAYMAN, Cayman Islands and COIMBATORE, India, July 08, 2024 (GLOBE NEWSWIRE) — SRIVARU Holding Limited (Nasdaq: SVMH; SVMHW) (“SRIVARU” […]
SciSparc Signs Non-Binding Letter of Intent for Spin Off of Advanced Clinical Stage Pharmaceutical Portfolio to Publicly Traded Company
According to the agreement, SciSparc’s pharmaceuticals assets are valued at approximately $11.6 million TEL AVIV, Israel, July 08, 2024 (GLOBE […]
HeartCore Partners with Hitachi Systems, Ltd. to Offer Combined Package of HeartCore CMS and GRED Web Security Assessment Cloud
NEW YORK and TOKYO, July 08, 2024 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a […]
Barfresh Dramatically Expands its Production Capacity by Adding Two New Third Party Locations
The New Capacity Will Cover the Company’s Full Range of Product Offerings, Including Approximately 25 Million of Additional Bottle Capacity […]
Gulf Resources Receives Extension from NASDAQ to Regain Compliance
SHOUGUANG, China, July 08, 2024 (GLOBE NEWSWIRE) — Gulf Resources, Inc. (Nasdaq: GURE) (“Gulf Resources”, “we,” or the “Company”), a […]
Lantheus Appoints Jamie Spaeth as Chief People Officer
BEDFORD, Mass., July 08, 2024 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling […]
GlobalFoundries Announces Conference Call to Review Second Quarter 2024 Financial Results
MALTA, N.Y., July 08, 2024 (GLOBE NEWSWIRE) — GlobalFoundries (NASDAQ: GFS) today announced that it will host a conference call […]
RenovoRx Announces Acceptance for Publication in the International Peer-Reviewed Journal, The Oncologist®
LOS ALTOS, Calif., July 08, 2024 (GLOBE NEWSWIRE) — RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical […]
